QUANTITATIVE PET/CT FOR MYOCARDIAL VIABILITY ASSESSMENT AFTER COMPLEX PCI: EXPLORING THE ROLE OF MICROBIAL INFECTIONS AND INFLAMMATORY BIOMARKERS
Main Article Content
Keywords
Myocardial viability, PET/CT, PCI, CRP, IL-6, microbial infection, inflammation, cardiac recovery
Abstract
To assess myocardial viability using quantitative PET/CT in patients following complex PCI and explore the role of microbial infections and inflammatory biomarkers in predicting myocardial recovery.
Methods: This prospective study included 71 patients who underwent complex PCI at Ayub Teaching Hospital, Abbottabad, between January 2023 and January 2024. PET/CT using 18F-FDG was performed post-PCI to evaluate myocardial viability. Blood samples were collected to analyze inflammatory biomarkers including CRP and IL-6. Microbial infection status was also assessed. Follow-up echocardiography was used to evaluate myocardial recovery.
Results: The majority of patients demonstrated viable myocardium on PET/CT imaging, with 60% of the cohort showing functional myocardial improvement on follow-up. Inflammatory biomarkers, including CRP and IL-6, were moderately elevated in several patients; however, statistical analysis revealed no significant association between these markers and myocardial recovery (p > 0.05). Infection was identified in nearly one-third of the patients. Among those with positive findings, Chlamydia pneumoniae was the most frequently detected organism (n = 15), followed by Helicobacter pylori (n = 11) and Cytomegalovirus (n = 4). Despite the presence of these pathogens, no statistically significant correlation was found between infection status or specific microbial species and myocardial recovery outcomes. The majority of patients (n = 41) had no detectable infection. These findings suggest that neither systemic inflammation nor underlying chronic infections had a measurable impact on post-PCI myocardial functional improvement in this study population.
Conclusion: Quantitative PET/CT proved to be a reliable imaging tool for assessing myocardial viability following complex PCI. Although inflammatory markers and microbial infections were prevalent among patients, their presence did not significantly influence myocardial recovery. This underscores the importance of direct metabolic myocardial assessment through PET/CT over reliance on systemic biomarkers or infection status when evaluating viability and guiding post-revascularization care.
References
2. Khalaf, S. and M.H. Al-Mallah, Fluorodeoxyglucose applications in cardiac PET: viability, inflammation, infection, and beyond. Methodist DeBakey cardiovascular journal, 2020. 16(2): p. 122.
3. Guaricci, A.I., et al., Computed tomography and nuclear medicine for the assessment of coronary inflammation: clinical applications and perspectives. Journal of Cardiovascular Medicine, 2023. 24(Supplement 1): p. e67-e76.
4. Habach, F., Characterization of Myocardial Metabolism using a novel Hybrid PET/MRI Protocol combining fasting and glucose loading. 2023, University of Toronto (Canada).
5. Cutshaw, G., et al., The emerging role of Raman spectroscopy as an omics approach for metabolic profiling and biomarker detection toward precision medicine. Chemical Reviews, 2023. 123(13): p. 8297-8346.
6. Werner, R.A., et al., The changing face of nuclear cardiology: guiding cardiovascular care toward molecular medicine. Journal of Nuclear Medicine, 2020. 61(7): p. 951-961.
7. Ståhle, M., MOLECULAR IMAGING AND IMMUNOTHERAPY IN ATHEROSCLEROTIC CARDIOVASCULAR.
8. Akbulut, A.C., et al., Blood coagulation and beyond: position paper from the Fourth Maastricht Consensus Conference on Thrombosis. Thrombosis and Haemostasis, 2023. 123(08): p. 808-839.
9. Broch, K., et al., Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 2021. 77(15): p. 1845-1855.
10. Dekker, M., Extracellular Vesicles for risk stratification in coronary artery disease: Trash or Treasure. 2022, Utrecht University.
11. Solanki, R., et al., Category: Cardiology. 2022.
12. Natale, L. and V. Bordonaro, Nonischaemic Acquired Heart Disease. Grainger & Allison’s Diagnostic Radiology, 2020: p. 315.
13. Almoslem, M.J.A., Pharmacokinetic and Pharmacodynamic Modeling for Optimizing Combination Therapy. 2023: University of Florida.
14. LEE, A.Y., Exploration of the tumor suppressor function of semaphorin 5A in brain cancer treatment. Frontiers in Pharmacology, 2021: p. 44.
15. Karpenko, Y.I., et al., Methodological development to the lectures on the educational discipline. Faculty, Course: International, IV. Academic discipline: Internal Medicine. 2022.
16. Plunde, O., Pathways linking atherosclerosis to aortic stenosis. 2022: Karolinska Institutet (Sweden).
17. Vaughan, H.J., et al., Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma. Science Advances, 2022. 8(29): p. eabo6406.
18. org, S.o.G.C.o.C.A.-C.A.s.c., CACA guidelines for holistic integrative management of gastric cancer. Holistic Integrative Oncology, 2022. 1(1): p. 3.
19. Philipp, M., et al., Feasibility of detecting altered parathyroid glands through interdisciplinary autopsy in a clinical forensic medicine setting. 2021.
20. Iddins, C.J., et al., Cutaneous and local radiation injuries. Journal of radiological protection, 2022. 42(1): p. 011001.